HIGHLIGHTS
- who: Aijuan Tian from the Patients and pathology The study was approved by the Ethics Committee of the Second Hospital of Dalian Medical University (2021-XJS-24), and all patients had informed consentPatients who were not obtained in the scheduled timeu2010frame, had incomplete clinical data, or whose lesions did not intake the radiotracer due to heterogeneity were excluded. Finally, patients with pathological diagnosis of prostate cancer underwent dual-phase , DCFPyL PET/CT in the Department of Nuclear Medicine of the Second Hospital of Dalian Medical University from , to , were included in the study. The characteristics of patients . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.